Waters EPS - Earnings per Share 2010-2025 | WAT
Waters annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Waters EPS for the quarter ending March 31, 2025 was $2.03, a 18.02% increase year-over-year.
- Waters EPS for the twelve months ending March 31, 2025 was $11.02, a 8.25% increase year-over-year.
- Waters 2024 annual EPS was $10.71, a 1.2% decline from 2023.
- Waters 2023 annual EPS was $10.84, a 7.59% decline from 2022.
- Waters 2022 annual EPS was $11.73, a 5.01% increase from 2021.
| Waters Annual EPS | |
|---|---|
| 2024 | $10.71 |
| 2023 | $10.84 |
| 2022 | $11.73 |
| 2021 | $11.17 |
| 2020 | $8.36 |
| 2019 | $8.69 |
| 2018 | $7.65 |
| 2017 | $0.25 |
| 2016 | $6.41 |
| 2015 | $5.65 |
| 2014 | $5.07 |
| 2013 | $5.20 |
| 2012 | $5.19 |
| 2011 | $4.69 |
| 2010 | $4.06 |
| 2009 | $3.34 |
| Waters Quarterly EPS | |
|---|---|
| 2025-03-31 | $2.03 |
| 2024-12-31 | $3.88 |
| 2024-09-30 | $2.71 |
| 2024-06-30 | $2.40 |
| 2024-03-31 | $1.72 |
| 2023-12-31 | $3.64 |
| 2023-09-30 | $2.27 |
| 2023-06-30 | $2.55 |
| 2023-03-31 | $2.38 |
| 2022-12-31 | $3.79 |
| 2022-09-30 | $2.60 |
| 2022-06-30 | $2.72 |
| 2022-03-31 | $2.62 |
| 2021-12-31 | $3.51 |
| 2021-09-30 | $2.60 |
| 2021-06-30 | $2.69 |
| 2021-03-31 | $2.37 |
| 2020-12-31 | $3.49 |
| 2020-09-30 | $2.03 |
| 2020-06-30 | $1.98 |
| 2020-03-31 | $0.86 |
| 2019-12-31 | $3.03 |
| 2019-09-30 | $2.07 |
| 2019-06-30 | $2.08 |
| 2019-03-31 | $1.51 |
| 2018-12-31 | $2.44 |
| 2018-09-30 | $1.83 |
| 2018-06-30 | $1.98 |
| 2018-03-31 | $1.40 |
| 2017-12-31 | $-4.38 |
| 2017-09-30 | $1.69 |
| 2017-06-30 | $1.63 |
| 2017-03-31 | $1.31 |
| 2016-12-31 | $2.16 |
| 2016-09-30 | $1.53 |
| 2016-06-30 | $1.57 |
| 2016-03-31 | $1.15 |
| 2015-12-31 | $1.83 |
| 2015-09-30 | $1.40 |
| 2015-06-30 | $1.27 |
| 2015-03-31 | $1.15 |
| 2014-12-31 | $1.78 |
| 2014-09-30 | $1.34 |
| 2014-06-30 | $1.13 |
| 2014-03-31 | $0.82 |
| 2013-12-31 | $1.64 |
| 2013-09-30 | $1.14 |
| 2013-06-30 | $1.03 |
| 2013-03-31 | $1.39 |
| 2012-12-31 | $2.00 |
| 2012-09-30 | $1.12 |
| 2012-06-30 | $1.09 |
| 2012-03-31 | $0.98 |
| 2011-12-31 | $1.51 |
| 2011-09-30 | $1.10 |
| 2011-06-30 | $1.07 |
| 2011-03-31 | $1.01 |
| 2010-12-31 | $1.35 |
| 2010-09-30 | $1.02 |
| 2010-06-30 | $0.90 |
| 2010-03-31 | $0.79 |
| 2009-12-31 | $1.08 |
| 2009-09-30 | $0.79 |
| 2009-06-30 | $0.72 |
| 2009-03-31 | $0.75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.101B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.994B | 86.72 |
| Thermo Fisher Scientific (TMO) | United States | $151.802B | 18.36 |
| Edwards Lifesciences (EW) | United States | $44.969B | 29.49 |
| Alcon (ALC) | Switzerland | $42.113B | 28.46 |
| IDEXX Laboratories (IDXX) | United States | $41.363B | 47.53 |
| DexCom (DXCM) | United States | $34.106B | 52.72 |
| STERIS (STE) | Ireland | $24.071B | 26.54 |
| Mettler-Toledo (MTD) | United States | $24.056B | 28.61 |
| IQVIA Holdings (IQV) | United States | $24.009B | 13.45 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.538B | 0.00 |
| Hologic (HOLX) | United States | $14.197B | 15.43 |
| Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
| Penumbra (PEN) | United States | $10.235B | 80.33 |
| Masimo (MASI) | United States | $8.405B | 31.00 |
| Globus Medical (GMED) | United States | $8.016B | 19.10 |
| Glaukos (GKOS) | United States | $5.426B | 0.00 |
| Teleflex (TFX) | United States | $5.351B | 8.83 |
| TransMedics (TMDX) | United States | $4.350B | 94.57 |
| Integer Holdings (ITGR) | United States | $4.166B | 21.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.244B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.333B | 13.89 |
| Nihon Kohden (NHNKY) | Japan | $2.223B | 25.49 |
| Veracyte (VCYT) | United States | $2.093B | 29.36 |
| Elekta AB (EKTAY) | Sweden | $2.075B | 18.66 |
| Alphatec Holdings (ATEC) | United States | $1.818B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.409B | 0.00 |
| Artivion (AORT) | United States | $1.271B | 119.04 |
| Pulse Biosciences (PLSE) | United States | $1.206B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.987B | 5.25 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.657B | 33.33 |
| RxSight (RXST) | United States | $0.654B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.575B | 8.94 |
| Delcath Systems (DCTH) | United States | $0.564B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.560B | 13.18 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.461B | 12.26 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| NeuroPace (NPCE) | United States | $0.409B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.368B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.253B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.187B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.40 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.71 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |